Taro Pharmaceutical Industries Ltd. reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was USD 139.2 million compared to USD 138.98 million a year ago. Net income was USD 7.27 million compared to USD 26.31 million a year ago. Basic earnings per share from continuing operations was USD 0.19 compared to USD 0.7 a year ago.
For the nine months, sales was USD 426.37 million compared to USD 418.08 million a year ago. Net income was USD 18.53 million compared to USD 30.86 million a year ago. Basic earnings per share from continuing operations was USD 0.49 compared to USD 0.82 a year ago.